Management of Elevated aPTT in Newborns

Understanding the Context First

Step 1: Assess the Clinical Context

Step 2: Identify the Cause

Common Causes of Elevated aPTT in Neonates

Step 3: Initial Workup

1. Repeat aPTT — exclude sample artifact (under-filled tube, heparin contamination from line)
2. CBC with platelets
3. PT/INR
4. Fibrinogen level
5. Thrombin time (if heparin contamination suspected)
6. Mixing study — if aPTT corrects → factor deficiency; if does not correct → inhibitor
7. Factor VIII and IX levels (if isolated aPTT elevation)
8. Liver function tests

Step 4: Management by Cause

1. Vitamin K Deficiency Bleeding (VKDB)

• Vitamin K₁ (phytomenadione) 1 mg IV/IM (term) or 0.3–0.5 mg/kg IV (preterm)
• For active hemorrhage: Fresh Frozen Plasma (FFP) 10–15 mL/kg IV for immediate factor replacement
• Monitor PT/aPTT every 4–6 hours

2. Hemophilia A (Factor VIII Deficiency)

• Recombinant Factor VIII concentrate — dose based on desired correction:
  • Minor bleed: 25 IU/kg → achieves ~50% factor level
  • Major/life-threatening bleed: 50 IU/kg → achieves ~100% level
• If factor unavailable: FFP 10–15 mL/kg as bridge
• Cryoprecipitate (contains FVIII, vWF, fibrinogen) as alternative: 1 unit per 5–10 kg

3. Hemophilia B (Factor IX Deficiency)

• Recombinant Factor IX concentrate
  • Minor bleed: 25–30 IU/kg
  • Major bleed: 50–100 IU/kg
• FFP if factor concentrate unavailable

4. DIC

• Treat the underlying cause (sepsis, NEC, asphyxia) — primary management
• Supportive coagulation replacement:
  • FFP 10–15 mL/kg if actively bleeding or invasive procedure planned
  • Cryoprecipitate if fibrinogen < 100 mg/dL (1 unit/5 kg)
  • Platelet transfusion if < 50,000 with bleeding (< 20,000 prophylactically)
• Heparin therapy is controversial in neonatal DIC; generally avoided

5. Liver Disease

• Vitamin K trial (1 mg IV) — often given empirically
• FFP 10–15 mL/kg if bleeding or procedure planned
• Treat underlying liver pathology

6. Heparin Contamination (Line Artifact)

• Re-draw from a peripheral vein, not a heparinized line
• No treatment required if aPTT normalizes on repeat

7. Physiological Prolongation (No Bleeding)

• Observation only — no treatment
• Repeat labs at 24–48 hours; aPTT normalizes by 6 months of age

Urgent/Life-Threatening Bleeding: Empirical Approach

1. Vitamin K 1 mg IV immediately
2. FFP 10–15 mL/kg IV over 30–60 minutes
3. Send full coagulation panel simultaneously
4. Consider cryoprecipitate if fibrinogen low
5. Neurosurgery/hematology consult for intracranial hemorrhage or severe hemophilia
6. Do NOT delay treatment waiting for lab confirmation in an actively bleeding neonate

Key Points

• Always check whether vitamin K prophylaxis was given at birth
• Heparin contamination is the most common artifactual cause — rule out first
• Isolated aPTT elevation with no bleeding and normal PT → think Hemophilia A/B or factor XII deficiency
• Combined PT + aPTT elevation → think VKDB, DIC, or liver disease
• Use age-specific neonatal reference ranges for aPTT (not adult values)